Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_assertion type Assertion NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_head.
- NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_assertion description "[Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_provenance.
- NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_assertion evidence source_evidence_literature NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_provenance.
- NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_assertion SIO_000772 17760744 NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_provenance.
- NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_assertion wasDerivedFrom gad-20130706 NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_provenance.
- NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_assertion wasGeneratedBy ECO_0000203 NP87596.RAth6pd9SEOgFsfQWZP4slc0cHgM2rCJ3_O1LA47Tr3fc130_provenance.